Dr. David Bart Reuben, MD

Dr. Reuben practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Reuben's NPI, 1427078690, was assigned on July 20, 2006. Dr. Reuben graduated from Emory School of Medicine in 1977. Dr. Reuben holds California license G66427.

Dr. Reuben's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Reuben's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Reuben is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Reuben to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reuben practices, 4 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Reuben's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Reuben is board certified in geriatric medicine by the American Board of Internal Medicine. Dmand AI has Dr. Reuben's licenses on file in 2 states: California and Rhode Island.

Dmand AI lists acute skin infection, acute stomach ulcer, alzheimer's disease, arthritis, atrial fibrillation and flutter, bile duct problems, cerebrovascular disease and chronic diabetes among the conditions Dr. Reuben treats.

CMS data shows 237 Medicare services from Dr. Reuben across 4 procedure codes in 2024, for 70 Medicare patients. Medicare paid $11,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Reuben in 2024. The largest group is 85 and over, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reuben's median patient age at 86, with 46% women.

In 2024, Dr. Reuben wrote 541 Medicare Part D claims for 44 patients. 84% of them were for generic drugs. CMS names the drug for 237 of them, across 15 drugs with 11 or more claims each, at $36,696 in total drug cost. In 2023, CMS named 486 claims across 25 drugs.

Dr. Reuben accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reuben as offering telehealth.

Dmand AI links 180 papers to Dr. Reuben, published from 2003 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Geriatrics, Geriatric Assessment and Activities of Daily Living. Dr. Reuben has published most often in J Am Geriatr Soc. Dr. Reuben's most frequent co-authors are Lee Alexandra Jennings, MD, Thomas M. Gill, MD and Joseph Gromer Ouslander, MD.

CMS Open Payments shows 1 general payment to Dr. Reuben from 1 drug or device company in 2016. Speaker and faculty fees make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $350.

Dmand AI lists 6 awards for Dr. Reuben, most recently America's Top Doctors in 2014.

Dr. Reuben graduated from Emory School of Medicine in 1977.

Dr. Reuben is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.